Stock AnalizNational Healthcare Corp. NHC
Hospital/Nursing Management · IPO 1986 · data as of November 13, 2026
National Healthcare Corp. (NHC) is a healthcare company listed in the US with a market value of about $3.3B. In the twelve months to September 30, 2026 it had revenue of $1.6B and net income of $115M, a net margin of 7.2%.
Its overall Stock Analiz score is 3.4 out of 5 (good). The strongest part is financial health (5/5); the weakest is value (2/5).
Key numbers: a P/E of 28.8, a price to free cash flow of 18.5, 5-year revenue growth of 8% a year, a 5-year average ROIC of 5%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 43% below the current price.
Score: 3.4 / 5
Checks passed
- P/FCF below 20
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- Profit margin improving
- 5-year EPS growth above 10% a year
- 5-year revenue growth above 8% a year
- Profitable 5 years in a row
Checks not passed
- P/E below 25
- P/E below the industry median
- Price below intrinsic value (DCF, moderate assumptions)
- 3-year free cash flow growth above 10% a year
- Strong R&D investment or growth above 20%
- 5-year average ROIC above 12%
- ROE above 15%
- Share count down over 3 years (buybacks)
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.6B | $1.5B | $1.3B | $1.1B | $1.1B | $1.1B | $1.0B | $996M | $980M | $964M | $924M |
| Net income | $115M | $120M | $102M | $67M | $22M | $139M | $42M | $68M | $59M | $56M | $51M |
| Free cash flow | $176M | $149M | $80M | $83M | -$21M | $23M | $181M | $74M | $69M | $62M | $28M |
| EPS (diluted) | $7.23 | $7.67 | $6.53 | $4.34 | $1.45 | $8.99 | $2.72 | $4.44 | $3.87 | $3.69 | $3.32 |
| Net margin | 7.2% | 7.9% | 7.8% | 5.9% | 2.1% | 12.9% | 4.1% | 6.9% | 6.0% | 5.8% | 5.5% |
| ROIC | — | 8.4% | 5.6% | 4.2% | 2.4% | 3.8% | 3.9% | 3.9% | 5.6% | 5.3% | 6.1% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
Frequently asked questions
What is National Healthcare’s P/E ratio?
About 28.8, based on the last twelve months of diluted earnings per share.
Is National Healthcare stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 43% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does National Healthcare pay a dividend?
Yes. The dividend yield is about 1.27%, and it has paid dividends for 10 years in our data.
Is National Healthcare a good stock to buy?
We do not give buy or sell advice. National Healthcare scores 3.4 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.